Literature DB >> 19688281

Cancer risk in a cohort of subjects carrying a single mismatch repair gene mutation.

D A Stupart1, P A Goldberg, U Algar, R Ramesar.   

Abstract

Hereditary non-polyposis colon cancer (HNPCC) is an autosomal dominant condition, caused by germline mutations in the mismatch repair genes, that presents with colorectal cancers at a young age, as well as extracolonic tumours. One of the causative mutations is the C1528T (Exon 13) mutation of the MLH1 gene. The purpose of this study is to document the cancer risk for subjects who carry this mutation. This is a prospective cohort study of 200 subjects who carry this mutation. We calculated the risk of developing colorectal cancer only in those subjects who had not undergone surveillance colonoscopy. The incidence of extracolonic cancers (for which surveillance is not routinely offered) was determined for the entire cohort. The results of the study are among the 71 subjects who did not undergo surveillance colonoscopy, colorectal cancers occurred in 36 (51%). They occurred at a median age of 44 years (range 17-73). Using Kaplan-Meier estimates, the risk of developing a colorectal cancer by age 65 was 92%. Eighteen subjects in the cohort of 200 were diagnosed with extracolonic tumours. The most common extracolonic malignancies were breast (6/98 women) and endometrial (3/98 women). Thus this mutation has a high penetrance for colorectal cancer, but is not associated with a high risk of developing extracolonic malignancies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19688281     DOI: 10.1007/s10689-009-9281-5

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  22 in total

1.  Surveillance colonoscopy improves survival in a cohort of subjects with a single mismatch repair gene mutation.

Authors:  D A Stupart; P A Goldberg; U Algar; R Ramesar
Journal:  Colorectal Dis       Date:  2009-02       Impact factor: 3.788

Review 2.  Mismatch repair genes hMLH1 and hMSH2 and colorectal cancer: a HuGE review.

Authors:  R J Mitchell; S M Farrington; M G Dunlop; H Campbell
Journal:  Am J Epidemiol       Date:  2002-11-15       Impact factor: 4.897

Review 3.  The tumor spectrum in the Lynch syndrome.

Authors:  Patrice Watson; Bronson Riley
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

4.  Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment.

Authors:  F Quehenberger; H F A Vasen; H C van Houwelingen
Journal:  J Med Genet       Date:  2005-06       Impact factor: 6.318

5.  The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma.

Authors:  Isis Dove-Edwin; Dominique Boks; Sheila Goff; Gemma G Kenter; Robert Carpenter; Hans F A Vasen; Huw J W Thomas
Journal:  Cancer       Date:  2002-03-15       Impact factor: 6.860

6.  Surveillance for endometrial cancer in hereditary nonpolyposis colorectal cancer syndrome.

Authors:  Laura Renkonen-Sinisalo; Ralf Bützow; Arto Leminen; Pentti Lehtovirta; Jukka-Pekka Mecklin; Heikki J Järvinen
Journal:  Int J Cancer       Date:  2007-02-15       Impact factor: 7.396

Review 7.  Cancer risk in mismatch repair gene mutation carriers.

Authors:  P Watson; H T Lynch
Journal:  Fam Cancer       Date:  2001       Impact factor: 2.375

8.  Risk of gynecologic cancers in Danish hereditary non-polyposis colorectal cancer families.

Authors:  Astrid Elisabeth Bruun Boilesen; Marie Luise Bisgaard; Inge Bernstein
Journal:  Acta Obstet Gynecol Scand       Date:  2008       Impact factor: 3.636

9.  The extracolonic cancer spectrum in females with the common 'South African' hMLH1 c.C1528T mutation.

Authors:  Maria M Blokhuis; Paul A Goldberg; G Elize Pietersen; Ursula Algar; A Alvera Vorster; Dhiren Govender; Raj S Ramesar
Journal:  Fam Cancer       Date:  2007-11-30       Impact factor: 2.375

10.  Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.

Authors:  H F Vasen; J T Wijnen; F H Menko; J H Kleibeuker; B G Taal; G Griffioen; F M Nagengast; E H Meijers-Heijboer; L Bertario; L Varesco; M L Bisgaard; J Mohr; R Fodde; P M Khan
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

View more
  7 in total

1.  Lynch syndrome: the influence of environmental factors on extracolonic cancer risk in hMLH1 c.C1528T mutation carriers and their mutation-negative sisters.

Authors:  M M Blokhuis; G E Pietersen; P A Goldberg; U Algar; L Van der Merwe; N Mbatani; A A Vorster; R S Ramesar
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

2.  Lynch syndrome-associated breast cancers: clinicopathologic characteristics of a case series from the colon cancer family registry.

Authors:  Michael D Walsh; Daniel D Buchanan; Margaret C Cummings; Sally-Ann Pearson; Sven T Arnold; Mark Clendenning; Rhiannon Walters; Diane M McKeone; Amanda B Spurdle; John L Hopper; Mark A Jenkins; Kerry D Phillips; Graeme K Suthers; Jill George; Jack Goldblatt; Amanda Muir; Kathy Tucker; Elise Pelzer; Michael R Gattas; Sonja Woodall; Susan Parry; Finlay A Macrae; Robert W Haile; John A Baron; John D Potter; Loic Le Marchand; Bharati Bapat; Stephen N Thibodeau; Noralane M Lindor; Michael A McGuckin; Joanne P Young
Journal:  Clin Cancer Res       Date:  2010-03-09       Impact factor: 12.531

3.  No evidence of genetic anticipation in a large family with Lynch syndrome.

Authors:  D Stupart; P Goldberg; U Algar; A Vorster; R Ramesar
Journal:  Fam Cancer       Date:  2014-03       Impact factor: 2.375

4.  The cost-effectiveness of routine testing for Lynch syndrome in newly diagnosed patients with colorectal cancer in the United States: corrected estimates.

Authors:  Scott D Grosse; Glenn E Palomaki; Mercy Mvundura; Heather Hampel
Journal:  Genet Med       Date:  2015-06       Impact factor: 8.822

5.  Economic evaluation of genetic screening for Lynch syndrome in Germany.

Authors:  Franziska Severin; Björn Stollenwerk; Elke Holinski-Feder; Elisabeth Meyer; Volker Heinemann; Clemens Giessen-Jung; Wolf Rogowski
Journal:  Genet Med       Date:  2015-01-08       Impact factor: 8.822

6.  Cost-Effectiveness Analysis of Different Genetic Testing Strategies for Lynch Syndrome in Taiwan.

Authors:  Ying-Erh Chen; Sung-Shuo Kao; Ren-Hua Chung
Journal:  PLoS One       Date:  2016-08-02       Impact factor: 3.240

7.  A Scoring Model and Protocol to Adapt Universal Screening for Lynch Syndrome to Identify Germline Pathogenic Variants by Next Generation Sequencing from Colorectal Cancer Patients and Cascade Screening.

Authors:  Ramadhani Chambuso; Barbara Robertson; Raj Ramesar
Journal:  Cancers (Basel)       Date:  2022-06-12       Impact factor: 6.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.